Pharma company GlaxoSmithKline is putting its nearly $700 million U.S. media assignment into review, the client has confirmed.
The incumbent is WPP Group’s MediaCom, which is expected to defend.
The client noted the last time GSK held a formal media review was in 2001, when MediaCom was awarded buying chores. In 2007, the client consolidated all planning duties with the agency as well.
The review covers all of GSK’s U.S. activities, which are comprised of two major divisions: consumer healthcare and pharmaceutical businesses.
According
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in